This inventor holds 4 USPTO granted patents. Top assignee: Sanofi. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: The Innovations of Jean-Francois Nave
Introduction
Jean-Francois Nave is a prominent inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of therapeutic applications for cardiovascular and nervous system disorders. With a total of four patents to his name, Nave's work is recognized for its potential impact on healthcare.
Latest Patents
Nave's latest patents include innovative uses of quinazolinedione derivatives. One of his notable inventions focuses on the therapeutic applications in the cardiovascular field. This invention involves the use of compounds in various forms as medicaments intended for the treatment and prevention of cardiovascular diseases. Another significant patent addresses the therapeutic uses of quinazolinedione derivatives for disorders associated with the central and peripheral nervous systems. These advancements highlight Nave's commitment to improving medical treatments.
Career Highlights
Jean-Francois Nave is currently associated with Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to collaborate with other experts in the field, further enhancing his contributions to medicinal chemistry. Nave's innovative spirit and dedication to research have positioned him as a key figure in the development of new therapeutic solutions.
Collaborations
Nave has worked alongside notable colleagues such as Gilbert Marciniak and Annie Clauss. These collaborations have fostered a dynamic environment for innovation and have contributed to the success of their joint research efforts.
Conclusion
Jean-Francois Nave's contributions to the field of medicinal chemistry through his patents and collaborations demonstrate his dedication to advancing healthcare solutions. His work continues to inspire future innovations in the treatment of cardiovascular and nervous system disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
